Literature DB >> 15729061

Gallbladder cancer: what is an aggressive approach?

Henry A Pitt1.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 15729061      PMCID: PMC1356977          DOI: 10.1097/01.sla.0000154119.55201.e9

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  8 in total

Review 1.  Gallbladder cancer: recent advances and current guidelines for surgical therapy.

Authors:  Y Fong; S Malhotra
Journal:  Adv Surg       Date:  2001

2.  An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American Center.

Authors:  Elijah Dixon; Charles M Vollmer; Ajay Sahajpal; Mark Cattral; David Grant; Christopher Doig; Al Hemming; Bryce Taylor; Bernard Langer; Paul Greig; Steven Gallinger
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

3.  Improved survival in resected biliary malignancies.

Authors:  Attila Nakeeb; Khoi Q Tran; Michael J Black; Beth A Erickson; Paul S Ritch; Edward J Quebbeman; Stuart D Wilson; Michael J Demeure; William S Rilling; Kulwinder S Dua; Henry A Pitt
Journal:  Surgery       Date:  2002-10       Impact factor: 3.982

4.  Treatment of gallbladder cancer by radical resection.

Authors:  T Todoroki; T Kawamoto; H Takahashi; Y Takada; N Koike; M Otsuka; K Fukao
Journal:  Br J Surg       Date:  1999-05       Impact factor: 6.939

5.  Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer?

Authors:  Yasuhito Shimizu; Masayuki Ohtsuka; Hiroshi Ito; Fumio Kimura; Hiroaki Shimizu; Akira Togawa; Hiroyuki Yoshidome; Atsushi Kato; Masaru Miyazaki
Journal:  Surgery       Date:  2004-11       Impact factor: 3.982

6.  Extensive surgery for carcinoma of the gallbladder.

Authors:  S Kondo; Y Nimura; N Hayakawa; J Kamiya; M Nagino; K Uesaka
Journal:  Br J Surg       Date:  2002-02       Impact factor: 6.939

7.  Regional and para-aortic lymphadenectomy in radical surgery for advanced gallbladder carcinoma.

Authors:  S Kondo; Y Nimura; N Hayakawa; J Kamiya; M Nagino; K Uesaka
Journal:  Br J Surg       Date:  2000-04       Impact factor: 6.939

8.  Combined pancreaticoduodenectomy and hepatectomy for patients with locally advanced gallbladder carcinoma: long term results.

Authors:  Y Shirai; T Ohtani; K Tsukada; K Hatakeyama
Journal:  Cancer       Date:  1997-11-15       Impact factor: 6.860

  8 in total
  7 in total

1.  The impact of tumor extent (T stage) and lymph node involvement (N stage) on survival after surgical resection for gallbladder adenocarcinoma.

Authors:  Victor Zaydfudim; Irene D Feurer; J Kelly Wright; C Wright Pinson
Journal:  HPB (Oxford)       Date:  2008       Impact factor: 3.647

2.  Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma.

Authors:  Woo Seok Kim; Dong Wook Choi; Dong Do You; Chuan Yu Ho; Jin Seok Heo; Seong Ho Choi
Journal:  J Gastrointest Surg       Date:  2010-01-22       Impact factor: 3.452

3.  Different expression of S100A8 in malignant and benign gallbladder diseases.

Authors:  Wei Wang; Kai-Xing Ai; Zhou Yuan; Xin-Yu Huang; Hui-Zhen Zhang
Journal:  Dig Dis Sci       Date:  2012-07-18       Impact factor: 3.199

4.  Synchronous double primary cancers associated with a choledochal cyst and anomalous pancreaticobiliary ductal union.

Authors:  Kang Kook Choi; Sae Byeol Choi; Seung Woo Park; Hyun Ki Kim; Young Nyun Park; Kyung Sik Kim
Journal:  J Korean Surg Soc       Date:  2011-10-28

Review 5.  Surgical management of gallbladder carcinoma: a review.

Authors:  Kristin L Mekeel; Alan W Hemming
Journal:  J Gastrointest Surg       Date:  2007-09       Impact factor: 3.452

6.  Operative approach to gallbladder cancer.

Authors:  Henry A Pitt; Attila Nakeeb
Journal:  Curr Gastroenterol Rep       Date:  2006-04

7.  The standardized surgical approach improves outcome of gallbladder cancer.

Authors:  Stefan Scheingraber; Christoph Justinger; Tatiana Stremovskaia; Malte Weinrich; Dorian Igna; Martin K Schilling
Journal:  World J Surg Oncol       Date:  2007-05-21       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.